Chinook Therapeutics Competitors and Similar CompaniesClear all

Chinook Therapeutics's competitors and similar companies include Mesoblast, Dr Lal PathLabs and Spark Therapeutics.

	Chinook Therapeutics Chinook Therapeutics is a biopharmaceutical company that develops precision medicines for kidney diseases.	Mesoblast Mesoblast specializes in the development of biologic products for the broad field of regenerative medicine.	Dr Lal PathLabs Dr Lal PathLabs is an international service provider of diagnostic and related healthcare tests.	Spark Therapeutics Spark Therapeutics is a gene therapy company.
Founding Date	Founding Date 2011	Founding Date 2004	Founding Date 1949	Founding Date 2013
Type	Type Subsidiary	Type Public	Type Public	Type Public
Tags	Tags Healthcare biotech drug development medical diagnostics pharma therapy	Tags Healthcare biotech medical diagnostics therapy	Tags Healthcare biotech medical diagnostics therapy	Tags Healthcare biotech medical diagnostics therapy
Locations	Locations Seattle, US HQ	Locations Melbourne, AU HQ Singapore, SG New York, US	Locations Gurugram, IN HQ	Locations Philadelphia, US HQ
Employees	Employees 27	Employees 73	Employees 4,099	Employees 36817% increase
Valuation ($)	Valuation ($) N/A	Valuation ($) 1.2 b	Valuation ($) N/A	Valuation ($) 4.4 b
Financial
Revenue (est.)	Revenue (est.) $6.1m (FY, 2022)	Revenue (est.) $17.2m (FY, 2025)	Revenue (est.) ₹27.6b (FY, 2026)	Revenue (est.) $64.7m (FY, 2018)
Cost of goods	Cost of goods N/A	Cost of goods $1.2m (FY, 2025)	Cost of goods ₹5.3b (FY, 2026)	Cost of goods N/A
Gross profit	Gross profit N/A	Gross profit $16.1m (FY, 2025)	Gross profit ₹23.3b (FY, 2026)	Gross profit N/A
Net income	Net income ($187.9m) (FY, 2022)	Net income ($102.1m) (FY, 2025)	Net income ₹5.1b (FY, 2026)	Net income ($78.8m) (FY, 2018)
Funding
Total funding raised	Total funding raised $ 171m	Total funding raised $ 56.2m	Total funding raised N/A	Total funding raised $ 122.8m